Opendata, web and dolomites
H2020 projects about "tumors"
The page lists 214 projects related to the topic "tumors".
| # | |||
|---|---|---|---|
| 1 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 2 | INTRAHETEROSEQ | Molecular characterization of the role of intra-tumor heterogeneity in cancer progression and metastasis | 2015 |
| 3 | DNAendProtection | DNA end protection in Immunity and Cancer | 2015 |
| 4 | Medulloblastoma | Molecularly defined models of human childhood brain tumors | 2015 |
| 5 | SQUALAC | Preclinical development of squalenic acid and gemcitabine squalene nanomedicine | 2015 |
| 6 | NDI | Nano-diamond tracers for MRI molecular imaging | 2014 |
| 7 | COLOStage | COLOStage : A new prognosis test for the prediction of metastasis in Colorectal Cancer and Hepatocellular Carcinoma | 2015 |
| 8 | Cancer-Targeted PolyIC | Treatment of EGFR over-expressing cancers by targeted non-viral delivery of PolyIC | 2015 |
| 9 | MAGICBULLET | Peptide-Drug Conjugates for Targeted Delivery in Tumor Therapy | 2015 |
| 10 | CancerHetero | Dissection of tumor heterogeneity in vivo | 2015 |
| 11 | FIBERSTAR | FIBER-optic sensors for Smart Thermal Ablation at Radiofrequency | 2016 |
| 12 | Cancer-Drug-Screen | High-throughput drug screening for identifying personalized cancer treatments tailored to the particular mutations of the patient’s tumor | 2015 |
| 13 | MoTOR | Analysis of the “moonlighting” proteins in the mTOR-signalling pathway | 2016 |
| 14 | KSHV QTV | Identification of novel KSHV immune evasion mechanisms using a quantitative temporal viromics analysis | 2015 |
| 15 | HspAdhesion | Role of cell membrane associated Hsp70 in cancer cell adhesion and metastasis | 2015 |
| 16 | MYO-DESMOPLASIA | Modulating the behaviour of cancer myofibroblasts to control tumour desmoplasia | 2015 |
| 17 | HGSOC | A novel approach into modeling origin and development of ovarian cancer | 2015 |
| 18 | FiBRO | Fibroblasts in the Biology of Rectal Cancer Progression | 2016 |
| 19 | MatrixMacrophages | Matrix degrading macrophages in cancer growth and invasion | 2015 |
| 20 | ACM | Cholesterol metabolism as a driver of prostate cancer aggressiveness | 2015 |
| 21 | Diricore | Exploiting vulnerabilities in protein synthesis for cancer diagnosis and therapy | 2015 |
| 22 | VIRION | Viruses, Immune stimulation and RNA Interference in Oncology Network | 2015 |
| 23 | IntraMEMS | Microfluidic platform for intra-operative tumor immunohistochemistry | 2015 |
| 24 | DDRNA | DDRNA-based cancer therapy targeted telomeres | 2015 |
| 25 | IRSkin | IRSkin provides dermatologists a new dermatoscope, equipped with a software for visual comparisons in the diagnostic phase, performing a content based Image Retrieval from an a-priori built database. | 2015 |
| 26 | PROTEOMICAN | Discovery of breast cancer aggressiveness markers using topo-proteomics mapping | 2015 |
| 27 | MetCAF | Uncovering the Role of Cancer Associated Fibroblasts in Facilitating Breast Cancer Metastasis | 2015 |
| 28 | LEGO | Multimodal glycoconjugates: a molecular Lego approach for antitumoral immunotherapy | 2015 |
| 29 | AUROMYC | N-Myc and Aurora A: From Protein Stability to Chromosome TopologyN-Myc and Aurora A: From Protein Stability to Chromosome TopologyMyc and Aurora A: From Protein Stability to Chromosome Topology | 2015 |
| 30 | DENOVOSTEM | DE NOVO GENERATION OF SOMATIC STEM CELLS: REGULATION AND MECHANISMS OF CELL PLASTICITY | 2015 |
| 31 | p38Cure | New breast cancer therapies based on available p38 MAPK inhibitors | 2015 |
| 32 | CholangioConcept | Functional in vivo analysis of cholangiocarcinoma development, progression and metastasis. | 2015 |
| 33 | PERIF | Perivascular cells at the crossroads of inflammation, regeneration and fibrosis | 2015 |
| 34 | Cancer-Recurrence | Tumor cell death supports recurrence of cancer | 2015 |
| 35 | ULTIMA | ULTrafast Imaging sensor for Medical Applications | 2015 |
| 36 | SLACC | Supplying lung adenocarcinoma cell lines to the cancer research community. | 2015 |
| 37 | BIOVALID | Clinical validation of the DiviTum assay in two high profile clinical studies in Europe | 2015 |
| 38 | PanCaT | Next-generation in vivo models for improved pancreatic cancer therapies | 2016 |
| 39 | HERCULES | Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis | 2016 |
| 40 | BD2Decide | Big Data and models for personalized Head and Neck Cancer Decision support | 2016 |
| 41 | EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers | 2016 |
| 42 | BARCODE DIAGNOSTICS | Next-Generation Personalized Diagnostic Nanotechnologies for Predicting Response to Cancer Medicine | 2016 |
| 43 | CONSALT | CONtrast through metal-enriched polymer SALTs: novel contrast agents for dual-energy micro-computed tomography | 2016 |
| 44 | INTEGRISTEM | Functions of Integrins in Mammary Stem Cell Activity and Tumorigenesis | 2016 |
| 45 | MolecularEVOLUTION | Molecular Evolution of the Primary Structure of Single Chain Polymer Nanoparticles via Dynamic Covalent Chemistry | 2016 |
| 46 | PERICYTEStroma | Pericyte-derived tumor stroma – a target for cancer therapy | 2016 |
| 47 | ENVERESP | Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity | 2016 |
| 48 | RAC | Defining the Role of Antioxidants on Cancer progression and metastasis | 2016 |
| 49 | SYNVIA | Synthetic viability of homologous recombination-deficient cancers | 2016 |
| 50 | Wnt and CRC | Therapeutic inhibition of the oncogenic Wnt/beta-catenin pathway in mismatch repair deficient hypermutant tumors | 2017 |
| 51 | WntELECT | Wnt Enhancer LandscapE CharacTerization | 2016 |
| 52 | 2MoveMate4Melanoma | A treatment for BRAF inhibitor resistant melanoma | 2016 |
| 53 | CLONCELLBREAST | CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT | 2017 |
| 54 | MYCLASS | Towards prevention, early diagnosis, and noninvasive treatment of uterine leiomyomas through molecular classification | 2016 |
| 55 | Lumiblast | A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours | 2016 |
| 56 | PeptiCrad | Personalized oncolytic vaccines for cancer immunotherapy | 2016 |
| 57 | Immune-senescence | Dual targeting of senescence and tumor immunity for cancer therapy | 2016 |
| 58 | TENSION | Targeting replication stress recovery pathways in oncology | 2016 |
| 59 | PLEIO-RANK | Pleiotropic treatment of cancer: RANK inhibitors targeting cancer stem cells and immunity | 2016 |
| 60 | TNT-TUMORS | Therapeutic approaches to enhance innate immunity against Tumors | 2016 |
| 61 | MARS | Mechanism of allosteric regulation of SHP2 phosphatase and its role in cancer and geneticdiseases: a multidisciplinary computational, structural and biological approach | 2017 |
| 62 | Project ACT | Automated autologous cell therapy system | 2016 |
| 63 | CoCa | Collagen in Cancer: from the regulatory fibril forming function of collagen V in development to its implication in tumor progression | 2016 |
| 64 | TRANSREAD | Restoration of tumor suppressor function by induction of translational read-through of premature termination codons - a strategy for improved cancer therapy | 2016 |
| 65 | FluoroDendriNostic | Combined fluorinated polymer and poly-L-lysine dendrimer as new potential contrast agents for magnetic resonance imaging 19F | 2016 |
| 66 | EN_ACTI2NG | European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry | 2017 |
| 67 | BIOCDx | A miniature Bio-photonics Companion Diagnostics platform for reliable cancer diagnosis and treatment monitoring. | 2017 |
| 68 | THERACAN | Novel therapeutic strategies to treat pancreatic and lung cancer | 2017 |
| 69 | iGBMavatars | Glioblastoma Subtype Avatar models for Target Discovery and Biology | 2017 |
| 70 | SLaMM | Magnetic Solid Lipid Nanoparticles as a Multifunctional Platform against Glioblastoma Multiforme | 2017 |
| 71 | ONCOCHECK | A simple blood test for prognosis and monitoring of patients undergoing cancer therapy. | 2017 |
| 72 | VIVAVE | Viral Vaccine Vectors in Personalized Medicine | 2017 |
| 73 | THUNDER | Development of the Cyclin-Dependent Kinase Inhibitor VS2-370 to Target HIV-associated Malignancies and to Purge Viral Reservoir | 2017 |
| 74 | PREDICT | PREcision medicine Drug combination testing In neuroblastoma organoids to guide Clinical Trials | 2017 |
| 75 | DREMATURE | DNA repair mechanisms and therapy resistance of BRCA2-deficient cancers | 2018 |
| 76 | ENDOCAM | TARGETING ENDOTHELIAL CELL AND CANCER AMOEBOID MOVEMENT TO OVERCOME RESISTANCE TO ANTI-VEGF AND ANTI-PROTEASE THERAPIES | 2017 |
| 77 | MSCFate | Fate of mammary stem cells during tumorigenesis and clinical implications | 2017 |
| 78 | DogSPEC | Multimodal Spectral Imaging for Canine Skin Erythema Estimation: from the Lab to the Clinic – DogSPEC | 2017 |
| 79 | TeloChromatin | Dissecting the chromatin dynamics at telomeres during mouse pre-implantation development. | 2017 |
| 80 | EwiSarc | A novel in vivo platform to study and target undruggable Ewing onco-chimera. | 2017 |
| 81 | pureCTC | A LAB-ON-A-CHIP DEVICE FOR PURE CIRCULATING TUMOR CELL ISOLATION FROM WHOLE BLOOD FOR CANCER THERAPY | 2017 |
| 82 | ONCOPHAGY | Novel Atg4B-inhibitors and dual [Atg4B-carbonic anhydrase]inhibitors for interfering with cytoprotective mechanisms of cancercells in the acidic tumor micro-environment. | 2017 |
| 83 | IC_IL_EC_2017 | Investigating the effects of immunogenic chemoradiation in shaping the immune landscape of esophageal cancers | 2018 |
| 84 | THAT IS HUNT | Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors | 2018 |
| 85 | Hepatocarcinoma IVM | Spatiotemporal dynamics of CD8+ T cell responses to hepatocellular carcinoma | 2017 |
| 86 | HEGEMONIC | HEpatocellular carcinoma GErmline MutatiONs ImpaCt (HEGEMONIC) | 2017 |
| 87 | ONCOSYSTEMS | Phenotypic characterization of Liver-derived exosomes populations associated with liver metastasis in pancreatic cancers | 2017 |
| 88 | INTUMORX | Elucidation of intratumoral heterogeneity in Kras-driven cancers | 2017 |
| 89 | TIGITtherapy | TIGIT therapy for cancer treatment | 2017 |
| 90 | BrachyDOSE | Developing a feasibility study for the future commercialization of BranchyDOSE – an innovative accurate and simple brachytherapy measurements tool | 2017 |
| 91 | ITCC-P4 | ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064 | 2017 |
| 92 | FATE | Functional Biology of Hepatic CD8+ T cells | 2017 |
| 93 | ENLIGHTEN | INTEGRATION AND PROPAGATION OF IMMUNOLOGICAL SIGNALS DURING CANCER AND INFECTION | 2018 |
| 94 | INTACt | ImmuNogenomics TArgeting Cancer | 2017 |
| 95 | scAssembly | Algorithms and experimental tools for integrating very large-scale single cell genomics data | 2017 |
| 96 | BioProbe-PIT | Local molecular profiling of tumor tissue sections: towards personalized immunotherapy | 2017 |
| 97 | u-PBeam | Microdosimetry study of a new radiation therapy method based on proton minibeams | 2017 |
| 98 | StroMaP | Stromal stress networks underlying phenotypic plasticity and tumor fitness | 2017 |
| 99 | ARMOR-T | Armoring multifunctional T cells for cancer therapy | 2018 |
| 100 | HYPER-INSIGHT | Hypermutated tumors: insight into genome maintenance and cancer vulnerabilities provided by an extreme burden of somatic mutations | 2018 |
| 101 | ImPRESS | Imaging Perfusion Restrictions from Extracellular Solid Stress | 2018 |
| 102 | MICRONEX | Microbioreactor platforms as in vivo-like systems to probe the role of Neuroblastoma-derived Exosomes in cancer dissemination | 2017 |
| 103 | TECNEC | Preclinical concept validation of tumor endothelial cell metabolism for novel anti-angiogenic therapy | 2017 |
| 104 | NANONC | Nanomaterials in Oncology: Exploiting the Intrinsic Cancer-Specific Toxicity of Nanoparticles. | 2018 |
| 105 | ProteaseNter | Disseminating N-terminomics to Advance Protease Research | 2018 |
| 106 | SENSIT | Sensitivity of human tumors to T cell attack | 2017 |
| 107 | NANOCARGO | Photo/magnetic stimulated nanocargos for superior cancer treatments | 2018 |
| 108 | MESI-STRAT | Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patient Stratification | 2018 |
| 109 | MTrix | Mechanical Targeting as an Integrative Approach for Personalized Nanomedicine | 2017 |
| 110 | CHIPS | Effects of Prenatal Exposure to Acrylamide on Health: Prospective Biomarker-Based Studies | 2018 |
| 111 | CANCER-DC | Dissecting Regulatory Networks That Mediate Dendritic Cell Suppression | 2018 |
| 112 | DualRP | Exploring cell interactions in the tumor microenvironment with dual ribosome profiling | 2018 |
| 113 | StemCellHabitat | Metabolic and Timed Control of Stem Cell Fate in the Developing Animal | 2018 |
| 114 | MATADOR | MAmmary chemoresistant Tumor deAth by Directed cell ORientation | 2018 |
| 115 | MyLeg | Smart and intuitive osseointegrated transfemoral prostheses embodying advanced dynamic behaviors | 2018 |
| 116 | MicroCaT | Micro-tumor Guided Cancer Therapy Selection MicroCaT | 2018 |
| 117 | P-ViTAL | The Precompetitive Steps of Virtual Transparency and Augmented Laparoscopy | 2018 |
| 118 | ImmunoFit | Harnessing tumor metabolism to overcome immunosupression | 2018 |
| 119 | ToCCaTa | Tailoring the functional Capacity of Cytotoxic T cells for future Therapies | 2018 |
| 120 | INSPIRE | Instrument Shape Sensing for Minimally Invasive Interventions | 2018 |
| 121 | ChemRAS | Chemical probing of transcriptional RAS effectors | 2019 |
| 122 | LASER OPTIMAL | Laser Ablation: SElectivity and monitoRing for OPTImal tuMor removAL | 2018 |
| 123 | SenPET | Innovative cancer management: First in human senescence imaging | 2018 |
| 124 | UTILIUM | Unraveling The Immune Landscape In Uveal Melanoma | 2018 |
| 125 | MHCIbiopic | MHC-I biogenesis and degradation at the endoplasmic reticulum membrane | 2019 |
| 126 | TheraSonix | Ultrasonic Imaging and Drug Propulsion Into Tumors Using Genetically Encoded Gas Nanostructures | 2018 |
| 127 | HifLICs | Acute Myeloid Leukemia Leukemic Initiating Cells: Contribution of hypoxia/HIF pathway to chemoresistance and relapse | 2019 |
| 128 | Proteasome in cancer | Identification of the proteasome machinery targets in human cancer | 2018 |
| 129 | IGpath | Dissecting the functional pathways of B cell receptor immunoglobulin in antigen driven mature B cell lymphomas | 2018 |
| 130 | UPDWMI | Ultra-low Power Digital circuits for Wireless Medical Implants | 2018 |
| 131 | VulneraBAP1 | Mechanism and vulnerability of BAP1 loss in tumor metastasis | 2018 |
| 132 | HiMIN | Histone H3.3 oncogenic mutations: a role in genome instability through altered DNA repair and replication fork stability? | 2018 |
| 133 | FUCTURE | Fucosylated Clusterin: a novel mechanism of tumor escape from immune response | 2018 |
| 134 | RadioClick | A versatile ultrafast Click platform for antibody based radio diagnostics | 2018 |
| 135 | pBioStrat-for-PDA | Use of PAP as a biomarker and stratifier of pancreatic cancer to improve patient management | 2018 |
| 136 | EDIT | Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma. | 2018 |
| 137 | TALVIN | Inhibiting mechanotransduction for the treatment of pancreatic cancer | 2018 |
| 138 | SENSITIVE | Early Detection of cancer onset based on sensing field cancerization at the organ level | 2018 |
| 139 | LIPOMET | Dietary Influences on Metastasis: How, When, and Why | 2018 |
| 140 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
| 141 | UNLEASHAD | Unleashing the curative potential of cancer immunotherapy | 2018 |
| 142 | SYST-iMYC | Development of an effective and safe systemic Myc inhibitor for the treatment of multiple cancer types. | 2018 |
| 143 | ONCOSMART | ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics | 2018 |
| 144 | PIcelles | Penetration-promoting and Imageable Polymeric Micelles as a Platform Technology for Individualized and Improved Tumor-targeted Drug Delivery | 2018 |
| 145 | CL-IO | Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis | 2018 |
| 146 | RNADIAGON | Excellence in research and development of non-coding RNA DIAGnostics in ONcology | 2019 |
| 147 | REACT | REsponsive theranostic nanosystems for Advanced Cancer Treatment | 2019 |
| 148 | EPIC | Enabling Precision Immuno-oncology in Colorectal cancer | 2018 |
| 149 | FunDiT | Functional Diversity of T cells | 2019 |
| 150 | STIMUNO | Searching for novel strategies improving cancer immunotherapy | 2019 |
| 151 | MitoGuide | Integration and adaptation of impaired mitochondrial fitness in orchestrating T cell dysfunction in the tumor microenvironment | 2019 |
| 152 | GLIOVACC | Augmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands | 2018 |
| 153 | PedSarc | Targeting genetic and epigenetic mechanisms in pediatric sarcomas. | 2019 |
| 154 | ESCALON | European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development | 2019 |
| 155 | SELNET | Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network | 2019 |
| 156 | TIL-FIT | Increasing the fitness of tumor-infiltrating T cells for cellular immunotherapy | 2019 |
| 157 | NanoBRIGHT | BRInGing nano-pHoTonics into the brain | 2019 |
| 158 | Epilepsy_Core | The core and effects of epilepsy: from chronic disease to curable disorder through innovative guided surgery | 2019 |
| 159 | ViroPedTher | Oncolytic viruses for the treatment of pediatric brain tumors: An integrated clinical and lab approach | 2019 |
| 160 | PROTONMBRT | Spatial fractionation of the dose in proton therapy: a novel therapeutic approach | 2019 |
| 161 | MyPal | MyPal: Fostering Palliative Care of Adults and Children with Cancer through Advanced Patient Reported Outcome Systems | 2019 |
| 162 | OrganoPlate Graft | Organ-on-a-Chip technology for in vitro grafting and vascularisation of 3D tissues | 2019 |
| 163 | CancerFingerPrints | Identification of nano-mechanical fingerprints as a biomarker for cancer treatment prognosis | 2019 |
| 164 | SECRETE-HF | SECRETED FACTORS IN CARDIAC REMODELING PROVOKE TUMORIGENESIS AND END ORGAN DAMAGE IN HEART FAILURE | 2019 |
| 165 | IntratumoralNiche | Defining heterocellular signalling within the intratumoral stem cell niche of colorectal cancer | 2019 |
| 166 | CRC-MTOs | Colorectal Cancer Mouse Tumor Organoids as Pre-clinical Models for Therapeutical Testing | 2018 |
| 167 | IMaP | Imaging tumor vessels as a marker for p53 mutation status in cancer | 2020 |
| 168 | Biosensor Design | Engineering Chemotactic Biosensors for a Diverse Spectrum of Metastatic Markers | 2020 |
| 169 | scTALLmap | Single-cell map of the composition and evolution of T-cell acute lymphoblastic leukemia | 2019 |
| 170 | Kinaddict | Vulnerability of esophageal cancer to their addiction to kinase activities: evaluation and prediction of eSCC tumors responsiveness to kinase inhibitors. | 2019 |
| 171 | REAP | Repair of DNA lesions induced by platinum drugs | 2019 |
| 172 | CApaCITy | CAncer Stem Cell Imunoreceptors as potential Targets for skin Squamous cell carcinoma | 2019 |
| 173 | GLIOHAB | Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation | 2019 |
| 174 | PCinBC | Plasma cell heterogeneity and dynamics in patient tumors | 2019 |
| 175 | ImmunoMECH | High-performance biomechanical model of combined immunotherapy and anti-angiogenic cancer treatment | 2019 |
| 176 | Exh-Res-CART | Exhaustion-resistant CAR-T cells for the treatment of solid tumours | 2019 |
| 177 | MetaTarGet | Targeting metabolic regulation in metastasis formation | 2019 |
| 178 | Tumor microbiome | The tumor microbial communities: Characterization, effects and translational opportunities | 2019 |
| 179 | BRAIN-MATCH | Matching CNS Lineage Maps with Molecular Brain Tumor Portraits for Translational Exploitation | 2019 |
| 180 | STREAM | Smart Textile foR hEAlth Monitoring | 2020 |
| 181 | SUPERBRAIN | Magneto-Plasmonic, Raman active Nanocapsules for Superior Pediatric Brain Cancer Therapy | 2020 |
| 182 | MAX-BAS | Magnetic cross-modal brain activity scanner MAX-BAS | 2019 |
| 183 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 184 | EPICAN | Inhibiting tumor cell plasticity by targeting the epigenome in breast cancer | 2020 |
| 185 | ONCO-BOOST | Boosting immuno-oncology strategies with innovative immuno-stimulants derived from bacteria, to be administrated in combination with therapeutic monoclonal antibodies | 2019 |
| 186 | 3DBrainStrom | Brain metastases: Deciphering tumor-stroma interactions in three dimensions for the rational design of nanomedicines | 2019 |
| 187 | Genetic Vaccine | Study the therapeutic and preventive potential of targeting oncogenic mutations with CRISPR-Cas9 technology | 2019 |
| 188 | NEXIM | A Next-generation targeted immuno-oncology therapy | 2019 |
| 189 | Anti-L1CAM | Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients | 2019 |
| 190 | TOPAS | Exploiting the Tumor Proteome Activity Status for Future Cancer Therapies | 2019 |
| 191 | TK-NEO | Personalized Cancer Immunotherapy through DNA-EP vaccines | 2019 |
| 192 | IMMUNOTRAP | Diagnosis test for immuno-oncology therapies. | 2019 |
| 193 | 3DCanPredict | Predicting clinical response to anticancer drugs using 3D-bioprinted tumor models for personalized therapy | 2019 |
| 194 | GelGeneCircuit | Cancer heterogeneity and therapy profiling using bioresponsive nanohydrogels for the delivery of multicolor logic genetic circuits. | 2020 |
| 195 | PROT-RESIST | Toward the Commercialization of a Proteolytically Resistant APPI Variant for Inhibiting Metastasis in Prostate and Pancreatic Cancer | 2019 |
| 196 | BD4QoL | Big Data Models and Intelligent tools for Quality of Life monitorinBig Data Models and Intelligent tools for Quality of Life monitoring and participatory empowerment of head and neck cancer survivors | 2020 |
| 197 | ONco-Energetics_OFF | Dissection of Bioenergetic Plasticity of Tumors | 2020 |
| 198 | RhabdoEvo | Deciphering the cellular origin and evolution of malignant rhabdoid tumors | 2019 |
| 199 | EVEREST | Extracellular Vesicles for Bone Regeneration – alternatives to Stem-cell Therapy | 2020 |
| 200 | MATCH | Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research | 2020 |
| 201 | Meta-Targeting | Macro-Nanomedicine to Treat Metastatic Cancer | 2020 |
| 202 | HyperCube | HyperCube: Gram scale production of ferrite nanocubes and thermo-responsive polymer coated nanocubes for medical applications and further exploitation in other hyperthermia fields | 2020 |
| 203 | TrojanDC | Harnessing dendritic cell reprogramming for cancer immunotherapy | 2020 |
| 204 | MelImmuneOrg | Deciphering the tumor-immune-microenvironment profile and organization within the tumors of melanoma patients undergoing immunotherapy | 2020 |
| 205 | TESTIMONY | Tumor Endothelial Cells: Gatekeepers Of Anti-Tumor Immunity | 2020 |
| 206 | cONCReTE | DevelOpmeNt of Cancer RNA TherapEutics | 2020 |
| 207 | NetriCan | Characterization of the role of netrin-1 in the regulation of the Epithelial-to-Mesenchymal Transition during tumor progression. | 2020 |
| 208 | GlioTarget | Inflaming the microenvironment of glioblastoma tumors by ADAR1 inhibition: a two-hit approach for the treatment of brain cancer. | 2021 |
| 209 | TARNEPC | Targeting treatment-induced neuroendocrine prostate cancer | 2021 |
| 210 | Pituitary enhancers | Identification and functional validation of novel enhancer sequences involved in pituitary gland development and pathology | 2020 |
| 211 | ONCO-VAX | A multifaceted cancer immunotherapy based on an immune checkpoint-modulating chimeric oncolytic virus vector in combination with a dendritic cell vaccine | 2020 |
| 212 | Immuno-Predictor | Mechanical Biomarkers for Prediction of Cancer Immunotherapy | 2020 |
| 213 | PRECISMEDLYM | Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine. | 2020 |
| 214 | ICG68-PROG | Imaging of c-Met aberrant cancers with Gallium-68 chelators for positron emission tomography | 2020 |